About This Cover
20 August 2016, Volume 3, Issue 8, pp. 793-924
Using an FDA clinically approved dye, an optofluidic laser is demonstrated with serological components, albumins and lipoproteins, as well as in human serum and whole blood.
See Chen et al., pp. 809-815.
See print version of the cover.